Clinical trial
Effects of ONO-2506PO in Patients With Alzheimer's Disease
NCT00083421 is registered in ClinicalTrials.gov with Ono Pharma USA Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of ONO-2506PO in Patients With Alzheimer's Disease
- Lead sponsor
- Ono Pharma USA Inc
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2004
- Completion date
- July 31, 2007
- Enrollment
- 647 (actual)
- Sites
- 87
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer's disease